CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $99,829
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-24 | Love Douglas PRESIDENT AND CEO | Purchase | +26,065 | $3.83 | $100K | 390,476 |
| 2026-08-10 | Blumenkranz Mark S. Director | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2026-06-11 | Cockroft Bettina M. Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-06-11 | Carson William H. Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-06-11 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Option exercise 10b5-1 | +30,646 | $1.85 | $57K | 184,807 |
| 2026-06-11 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,646 | 0 | ||
| 2026-06-11 | Choi Jung Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-06-11 | Waddill William D. Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-06-11 | JONES WILLIAM A JR Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-06-11 | Satter Muneer A Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2026-05-28 | Satter Muneer A Director | Purchase | +613,497 | $5.41 | $3.3M | 10,342,134 |
| 2026-05-11 | Carson William H. Director | Purchase 10b5-1 | +8,000 | $5.78 | $46K | 78,405 |
| 2026-04-10 | Carson William H. Director | Purchase 10b5-1 | +8,000 | $6.20 | $50K | 70,405 |
| 2026-03-10 | Carson William H. Director | Purchase 10b5-1 | +8,000 | $5.67 | $45K | 62,405 |
| 2026-03-02 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Sale | −5,894 | $5.43 | $32K | 180,093 |
| 2026-03-02 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −5,566 | $5.42 | $30K | 154,161 |
| 2026-03-02 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −4,339 | $5.42 | $24K | 182,625 |
| 2026-03-02 | Dananberg Jamie CHIEF MEDICAL OFFICER | Sale | −5,820 | $5.43 | $32K | 123,582 |
| 2026-03-02 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −5,565 | $5.42 | $30K | 170,700 |
| 2026-02-19 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Grant or award | +62,500 | 185,987 |
Page 1 of 15 · 292 trades